Introducing a first AIDS vaccine in Switzerland: A Policy Delphi analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-03

AUTHORS

Patrick L. F. Zuber, Jonathan M. Mann, Fred Paccaud, Michael R. Reich, Murray Turoff

ABSTRACT

This preliminary exploration was limited by a number of factors. The format of the study has necessarily induced some form of selection bias of the panelists, because of the complexity of some questions, and the time required to complete the questionnaires. Several issues have not been addressed. One example could be the response to HIV infection occurring in a vaccinee. The study also did not address the difficulties related to the licensing of the vaccine. Indeed, the proposed scenario assumed that the vaccine had been registered as a starting point for the analysis. Finally, it has not been possible to conduct a sensitivity analysis, in order to evaluate how the responses would have been modified if some important characteristics of the vaccine had been modified. Very diverse evaluations were given in response to questions related with attitudes and perception of AIDS and AIDS vaccine. The possibility that vaccine availability or usage can be associated with an increased frequency in risky behaviors was spontaneously mentioned by half of the panelists. The estimation of the proportion of persons at highest risk who would choose to use this vaccine also indicated a high degree of uncertainty. This study offers important lessons. According to a broad and diverse panel of individuals, an incompletely effective AIDS vaccine would result in an additional level of complexity for the AIDS prevention strategy, rather than a simplification. The use of such a vaccine would have to be coupled with counselling. This implies a sustained emphasis on the recommendations which have been central to the STOP AIDS campaigns until now. In addition, consensual issues, as well as other issues more likely to be controversial have been identified. This should greatly help focusing the work of any committee designated to develop and implement a vaccination policy if an AIDS vaccine became available. Finally, our experience with the Policy Delphi indicates that this mode of structured communication could be usefully applied to other public health issues presenting a high visibility as well as a complex relationship with public perception. More... »

PAGES

126-127

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01323091

DOI

http://dx.doi.org/10.1007/bf01323091

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024118121

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8693807


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "AIDS Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acquired Immunodeficiency Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Delphi Technique", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Policy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Public Health", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Switzerland", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Takemi Program in International Health, Harvard School of Public Health, Boston"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zuber", 
        "givenName": "Patrick L. F.", 
        "id": "sg:person.01017114363.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017114363.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Fran\u00e7ois-Xavier Bagnoud Center for Health and Human Rights, Harvard School of Public Health, Boston"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mann", 
        "givenName": "Jonathan M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Social and Preventive Medicine", 
          "id": "https://www.grid.ac/institutes/grid.482968.9", 
          "name": [
            "Institute of Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paccaud", 
        "givenName": "Fred", 
        "id": "sg:person.01174165511.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174165511.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Takemi Program in International Health, Harvard School of Public Health, Boston"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reich", 
        "givenName": "Michael R.", 
        "id": "sg:person.0600377700.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600377700.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "New Jersey Institute of Technology", 
          "id": "https://www.grid.ac/institutes/grid.260896.3", 
          "name": [
            "New Jersey Institute of Technology, Newark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Turoff", 
        "givenName": "Murray", 
        "id": "sg:person.013645375313.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013645375313.84"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1996-03", 
    "datePublishedReg": "1996-03-01", 
    "description": "This preliminary exploration was limited by a number of factors. The format of the study has necessarily induced some form of selection bias of the panelists, because of the complexity of some questions, and the time required to complete the questionnaires. Several issues have not been addressed. One example could be the response to HIV infection occurring in a vaccinee. The study also did not address the difficulties related to the licensing of the vaccine. Indeed, the proposed scenario assumed that the vaccine had been registered as a starting point for the analysis. Finally, it has not been possible to conduct a sensitivity analysis, in order to evaluate how the responses would have been modified if some important characteristics of the vaccine had been modified. Very diverse evaluations were given in response to questions related with attitudes and perception of AIDS and AIDS vaccine. The possibility that vaccine availability or usage can be associated with an increased frequency in risky behaviors was spontaneously mentioned by half of the panelists. The estimation of the proportion of persons at highest risk who would choose to use this vaccine also indicated a high degree of uncertainty. This study offers important lessons. According to a broad and diverse panel of individuals, an incompletely effective AIDS vaccine would result in an additional level of complexity for the AIDS prevention strategy, rather than a simplification. The use of such a vaccine would have to be coupled with counselling. This implies a sustained emphasis on the recommendations which have been central to the STOP AIDS campaigns until now. In addition, consensual issues, as well as other issues more likely to be controversial have been identified. This should greatly help focusing the work of any committee designated to develop and implement a vaccination policy if an AIDS vaccine became available. Finally, our experience with the Policy Delphi indicates that this mode of structured communication could be usefully applied to other public health issues presenting a high visibility as well as a complex relationship with public perception.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf01323091", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1038584", 
        "issn": [
          "1661-8556", 
          "1661-8564"
        ], 
        "name": "International Journal of Public Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "41"
      }
    ], 
    "name": "Introducing a first AIDS vaccine in Switzerland: A Policy Delphi analysis", 
    "pagination": "126-127", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "72e7269d25b4851f0eaa8d4db405b94ceca2d01e20569d150f63cacc2ce21a9c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8693807"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7502479"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01323091"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024118121"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01323091", 
      "https://app.dimensions.ai/details/publication/pub.1024118121"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000488.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF01323091"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01323091'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01323091'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01323091'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01323091'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      20 PREDICATES      36 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01323091 schema:about N254154fa43584ed2a97a722addecc35f
2 N3a984ef2966b4a798add4f5f652dc67e
3 N48818ace2c924c77b6dc31292ce02626
4 N71550d9e9a3a49ddbcbec980bb4df734
5 N95e8e4d363aa4fd4948eb3f74eca05c1
6 Nb73bfce6e9184e2baf758291e1a82d9c
7 Ne9e60d3afeaa43a4b79392481373d11e
8 anzsrc-for:11
9 anzsrc-for:1117
10 schema:author N6c41d6efb3534d1a8ed544797a5a5e60
11 schema:datePublished 1996-03
12 schema:datePublishedReg 1996-03-01
13 schema:description This preliminary exploration was limited by a number of factors. The format of the study has necessarily induced some form of selection bias of the panelists, because of the complexity of some questions, and the time required to complete the questionnaires. Several issues have not been addressed. One example could be the response to HIV infection occurring in a vaccinee. The study also did not address the difficulties related to the licensing of the vaccine. Indeed, the proposed scenario assumed that the vaccine had been registered as a starting point for the analysis. Finally, it has not been possible to conduct a sensitivity analysis, in order to evaluate how the responses would have been modified if some important characteristics of the vaccine had been modified. Very diverse evaluations were given in response to questions related with attitudes and perception of AIDS and AIDS vaccine. The possibility that vaccine availability or usage can be associated with an increased frequency in risky behaviors was spontaneously mentioned by half of the panelists. The estimation of the proportion of persons at highest risk who would choose to use this vaccine also indicated a high degree of uncertainty. This study offers important lessons. According to a broad and diverse panel of individuals, an incompletely effective AIDS vaccine would result in an additional level of complexity for the AIDS prevention strategy, rather than a simplification. The use of such a vaccine would have to be coupled with counselling. This implies a sustained emphasis on the recommendations which have been central to the STOP AIDS campaigns until now. In addition, consensual issues, as well as other issues more likely to be controversial have been identified. This should greatly help focusing the work of any committee designated to develop and implement a vaccination policy if an AIDS vaccine became available. Finally, our experience with the Policy Delphi indicates that this mode of structured communication could be usefully applied to other public health issues presenting a high visibility as well as a complex relationship with public perception.
14 schema:genre research_article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf Ne6fba35b589d4b84a8cf0f117899b08e
18 Ne8b2531b38434b61869941020403619b
19 sg:journal.1038584
20 schema:name Introducing a first AIDS vaccine in Switzerland: A Policy Delphi analysis
21 schema:pagination 126-127
22 schema:productId N1c56ad1ba33a4b83aee05cfeee5a080d
23 N2c2aed83661546e68156d10277a20af8
24 N61ac124578f34d1dbd70dce1d8d029fe
25 N6cc7bbc50175485788451ff78d29865e
26 N9434990a29294f94829dfacd188773a4
27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024118121
28 https://doi.org/10.1007/bf01323091
29 schema:sdDatePublished 2019-04-10T16:36
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N7350d348433848ce8bb214cf3347ed1c
32 schema:url http://link.springer.com/10.1007/BF01323091
33 sgo:license sg:explorer/license/
34 sgo:sdDataset articles
35 rdf:type schema:ScholarlyArticle
36 N1c56ad1ba33a4b83aee05cfeee5a080d schema:name nlm_unique_id
37 schema:value 7502479
38 rdf:type schema:PropertyValue
39 N254154fa43584ed2a97a722addecc35f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
40 schema:name Humans
41 rdf:type schema:DefinedTerm
42 N2c2aed83661546e68156d10277a20af8 schema:name doi
43 schema:value 10.1007/bf01323091
44 rdf:type schema:PropertyValue
45 N334ec44af19647a78d3e697ff86b65fa schema:affiliation N9eaf654bbde441bca6a63ddf2020e7e0
46 schema:familyName Mann
47 schema:givenName Jonathan M.
48 rdf:type schema:Person
49 N3a984ef2966b4a798add4f5f652dc67e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name AIDS Vaccines
51 rdf:type schema:DefinedTerm
52 N4846ac3a16e44772976ba509c0d97f7f rdf:first N334ec44af19647a78d3e697ff86b65fa
53 rdf:rest N7e5da51426dc491981bfc70cfb8bbe6f
54 N48818ace2c924c77b6dc31292ce02626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Delphi Technique
56 rdf:type schema:DefinedTerm
57 N61ac124578f34d1dbd70dce1d8d029fe schema:name pubmed_id
58 schema:value 8693807
59 rdf:type schema:PropertyValue
60 N6c41d6efb3534d1a8ed544797a5a5e60 rdf:first sg:person.01017114363.87
61 rdf:rest N4846ac3a16e44772976ba509c0d97f7f
62 N6cc7bbc50175485788451ff78d29865e schema:name readcube_id
63 schema:value 72e7269d25b4851f0eaa8d4db405b94ceca2d01e20569d150f63cacc2ce21a9c
64 rdf:type schema:PropertyValue
65 N71550d9e9a3a49ddbcbec980bb4df734 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Switzerland
67 rdf:type schema:DefinedTerm
68 N7350d348433848ce8bb214cf3347ed1c schema:name Springer Nature - SN SciGraph project
69 rdf:type schema:Organization
70 N7e5da51426dc491981bfc70cfb8bbe6f rdf:first sg:person.01174165511.60
71 rdf:rest Nc4d7bee4019b426fb1eb093d33501523
72 N9434990a29294f94829dfacd188773a4 schema:name dimensions_id
73 schema:value pub.1024118121
74 rdf:type schema:PropertyValue
75 N95e8e4d363aa4fd4948eb3f74eca05c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Public Health
77 rdf:type schema:DefinedTerm
78 N9eaf654bbde441bca6a63ddf2020e7e0 schema:name François-Xavier Bagnoud Center for Health and Human Rights, Harvard School of Public Health, Boston
79 rdf:type schema:Organization
80 Nb73bfce6e9184e2baf758291e1a82d9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Acquired Immunodeficiency Syndrome
82 rdf:type schema:DefinedTerm
83 Nc4d7bee4019b426fb1eb093d33501523 rdf:first sg:person.0600377700.09
84 rdf:rest Ne98bf29f24c24ce799499d277e4b11d8
85 Nd713940e4f6149bfb97612d70880acfe schema:name Takemi Program in International Health, Harvard School of Public Health, Boston
86 rdf:type schema:Organization
87 Ne485dfbbd2aa4bd8a5737826f5b65478 schema:name Takemi Program in International Health, Harvard School of Public Health, Boston
88 rdf:type schema:Organization
89 Ne6fba35b589d4b84a8cf0f117899b08e schema:issueNumber 2
90 rdf:type schema:PublicationIssue
91 Ne8b2531b38434b61869941020403619b schema:volumeNumber 41
92 rdf:type schema:PublicationVolume
93 Ne98bf29f24c24ce799499d277e4b11d8 rdf:first sg:person.013645375313.84
94 rdf:rest rdf:nil
95 Ne9e60d3afeaa43a4b79392481373d11e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Health Policy
97 rdf:type schema:DefinedTerm
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
102 schema:name Public Health and Health Services
103 rdf:type schema:DefinedTerm
104 sg:journal.1038584 schema:issn 1661-8556
105 1661-8564
106 schema:name International Journal of Public Health
107 rdf:type schema:Periodical
108 sg:person.01017114363.87 schema:affiliation Ne485dfbbd2aa4bd8a5737826f5b65478
109 schema:familyName Zuber
110 schema:givenName Patrick L. F.
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017114363.87
112 rdf:type schema:Person
113 sg:person.01174165511.60 schema:affiliation https://www.grid.ac/institutes/grid.482968.9
114 schema:familyName Paccaud
115 schema:givenName Fred
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174165511.60
117 rdf:type schema:Person
118 sg:person.013645375313.84 schema:affiliation https://www.grid.ac/institutes/grid.260896.3
119 schema:familyName Turoff
120 schema:givenName Murray
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013645375313.84
122 rdf:type schema:Person
123 sg:person.0600377700.09 schema:affiliation Nd713940e4f6149bfb97612d70880acfe
124 schema:familyName Reich
125 schema:givenName Michael R.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600377700.09
127 rdf:type schema:Person
128 https://www.grid.ac/institutes/grid.260896.3 schema:alternateName New Jersey Institute of Technology
129 schema:name New Jersey Institute of Technology, Newark
130 rdf:type schema:Organization
131 https://www.grid.ac/institutes/grid.482968.9 schema:alternateName Institute of Social and Preventive Medicine
132 schema:name Institute of Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland
133 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...